GODREJAGRO

Godrej Agrovet share price & financials

Price
₹567.8
Market cap
₹10.6k Cr
Sector
Fast Moving Consumer Goods
Calls analysed
7
Latest concall · Q1 FY27 · call held 06 Aug 2026

Godrej Agrovet Limited Q1 FY27

Consolidated Sales ₹2,852 cr +10%

What went well

  • Consolidated sales grew 10% YoY to ₹2,852 crores despite challenging environment.
  • Animal Nutrition delivered strong performance with 12.6% revenue growth and 29% segment result growth, driven by robust demand and improved realizations.
  • Oil Palm continued growth momentum with 28.9% revenue and 14.4% segment result growth, supported by higher CPO/PKO realizations and improved oil extraction efficiency.

What to watch

  • Crop Care business revenue declined 16.2% due to delayed monsoon and slower kharif sowing, impacting volumes and overall profitability.
  • Dairy profitability was affected by elevated milk procurement prices and inflation in other inputs.
Read the full call →

What Godrej Agrovet Limited does

Godrej Agrovet is a diversified, R&D-oriented Indian agri-business operating across five verticals: animal nutrition (compound feed for cattle, poultry, fish and shrimp), oil palm (cultivation and processing into Crude Palm Oil and Palm Kernel Oil), crop protection/agrochemicals (via subsidiary Astec LifeSciences), dairy (via Creamline Dairy Products in Southern India) and poultry & processed foods (via wholly owned Godrej Foods Limited). It earns by manufacturing and selling compound feed to livestock and aqua farmers, processing palm fresh fruit bunches into edible oils, formulating and selling crop-care chemicals (including contract development and manufacturing for other companies), and processing and branding dairy and poultry/meat products for retail and institutional customers. It also holds a Bangladesh joint venture, ACI Godrej Agrovet, and is part of the Godrej Industries Group.

Segments

  • Animal Nutrition
  • Oil Palm
  • Crop Care
  • Dairy
  • Poultry & Processed Foods
  • Others
Manufacturing units (pan-India, across businesses)
60+
Animal feed manufacturing plants
30+
Market position — Animal Nutrition
Leading compound animal feed player in India across cattle, broiler, layer, fish and shrimp feed
Market position — Oil Palm
Largest producer of Crude Palm Oil (CPO) and Palm Kernel Oil (PKO) in India
R&D centres
Dedicated centres for Animal Nutrition (Nashik), Aqua Feed (Hanuman Junction, Andhra Pradesh), Chemical R&D (Rabale, Maharashtra — Astec LifeSciences) and an Oil Palm R&D farm (40 acres)
Group companies
Astec LifeSciences (listed agrochemicals subsidiary), Creamline Dairy Products, Godrej Foods Limited (wholly owned) and ACI Godrej Agrovet (Bangladesh joint venture)
Headquarters Mumbai, Maharashtra Company website

Guidance record · Q1 FY27

what the last two calls moved 25 tracked 4 delivered 5 missed 16 open
  • Astec LifeSciences CDMO Growth FY25 delivered said Q3 FY25 Promised: Flat / No Growth Q1 FY27: Historical promise for FY25, which was achieved. No further updates.
  • Consolidated Revenue Growth missed said Q4 FY25 Promised: 16% to 18% Q1 FY27: Historical promise for FY26, which was officially missed. No further updates.
  • Consolidated PBT Growth FY27 revised down said Q4 FY26 Promised: Mid-strong double-digit, mid-teens Q1 FY27: Guidance revised down from 'mid-strong double-digit, mid-teens' to just 'double-digit growth', with management to provide a specific range in Q2.

All 25 tracked — every revision, and every one management stopped mentioning.

Open the guidance ledger

Quarterly results

Q1 FY27: revenue up 9.9%, net profit up 8.9% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue1,848 1,869 1,550 2,007 2,000 +8%2,070 +11%1,668 +8%2,205 +10%
EBITDA222 195 130 259 196 −12%212 +9%105 −19%228 −12%
Net profit132 166 68 169 177 +34%116 −30%65 −4%184 +9%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −8.7% 1Y

₹500₹550₹600₹650₹700₹750Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Q2 FY26 — 6 Nov 2025Q3 FY26 — 4 Feb 2026Q4 FY26 — 4 May 2026Q1 FY27 — 6 Aug 2026

1Y: ₹740.6 on 10 Sept 2025 → ₹675.85. High ₹740.6 (10 Sept 2025), low ₹513 (23 Jan 2026).

How the price took the results

close before → close after

Q1 FY27
−3.7%
6 Aug
Q4 FY26
−1.3%
4 May
Q3 FY26
+1.8%
4 Feb
Q2 FY26
−4.7%
6 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Financials, as filed

Revenue fell 4.1% a year over 3 years, FY23 to FY26. Operating margin widened to 10.0%.

Year endingFY23FY24FY25FY26
Revenue₹8.8k Cr₹7.1k Cr₹7.0k Cr₹7.7k Cr
Operating profit₹517 Cr₹576 Cr₹761 Cr₹772 Cr
Operating margin5.9%8.1%10.9%10.0%
Interest₹89 Cr₹62 Cr₹84 Cr₹86 Cr
Depreciation₹164 Cr₹120 Cr₹123 Cr₹128 Cr
Net profit₹304 Cr₹356 Cr₹502 Cr₹527 Cr
Net margin3.5%5.0%7.2%6.8%
ROCE13.0%18.0%24.0%22.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹192 Cr₹192 Cr₹192 Cr₹192 Cr₹192 Cr₹192 Cr
Reserves₹1.6k Cr₹1.8k Cr₹1.9k Cr₹2.1k Cr₹1.6k Cr₹2.7k Cr
Borrowings₹729 Cr₹1.0k Cr₹841 Cr₹689 Cr₹2.2k Cr₹862 Cr
Other liabilities₹749 Cr₹825 Cr₹823 Cr₹959 Cr₹2.1k Cr₹2.1k Cr
Total liabilities₹3.2k Cr₹3.8k Cr₹3.7k Cr₹3.9k Cr₹6.1k Cr₹5.8k Cr
Fixed assets₹1.0k Cr₹1.0k Cr₹1.2k Cr₹1.3k Cr₹2.9k Cr₹1.3k Cr
Capital work in progress₹15 Cr₹62 Cr₹63 Cr₹22 Cr₹134 Cr₹181 Cr
Investments₹596 Cr₹686 Cr₹755 Cr₹772 Cr₹93 Cr₹2.2k Cr
Other assets₹1.6k Cr₹2.1k Cr₹1.8k Cr₹1.8k Cr₹3.0k Cr₹2.2k Cr
Total assets₹3.2k Cr₹3.8k Cr₹3.7k Cr₹3.9k Cr₹6.1k Cr₹5.8k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, FIIs trimmed −0.79 pp while DIIs added +0.31 pp. The shareholder count shrank 4% to 1,14,250.

Promoters
67.8%
FIIs
6.5%
DIIs
5.3%
Public
20.5%

Since Jun 2025

  • FIIs −0.79 pp
  • DIIs +0.31 pp
  • Public +0.27 pp

How it drifted, 12 quarters

Over this window the public went from 11.3% to 20.5% — +9.2 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 74.0%, FIIs 9.6%, DIIs 5.1%, Public 11.3%.Dec '23: Promoters 74.0%, FIIs 9.4%, DIIs 5.5%, Public 11.0%.Mar '24: Promoters 74.0%, FIIs 9.4%, DIIs 5.1%, Public 11.4%.Jun '24: Promoters 74.0%, FIIs 9.5%, DIIs 4.3%, Public 12.1%.Sep '24: Promoters 74.0%, FIIs 7.5%, DIIs 5.9%, Public 12.6%.Dec '24: Promoters 67.6%, FIIs 7.1%, DIIs 6.3%, Public 19.1%.Mar '25: Promoters 67.6%, FIIs 7.5%, DIIs 5.5%, Public 19.5%.Jun '25: Promoters 67.5%, FIIs 7.3%, DIIs 5.0%, Public 20.2%.Sep '25: Promoters 67.5%, FIIs 7.2%, DIIs 5.2%, Public 20.1%.Dec '25: Promoters 67.7%, FIIs 6.3%, DIIs 5.4%, Public 20.7%.Mar '26: Promoters 67.8%, FIIs 6.3%, DIIs 5.9%, Public 20.1%.Jun '26: Promoters 67.8%, FIIs 6.5%, DIIs 5.3%, Public 20.5%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Godrej Agrovet Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Godrej Industries Limited 65.05%unchanged
V-Sciences Investments Pte Ltd FPI fund2.43%unchanged
Nippon Life India Trustee Ltd-A/C Nippon India Mul Mutual fund2.09%unchanged
Balram Singh Yadav 1.74%unchanged
Life Insurance Corporation Of India Insurer1.21%unchanged
Smita Godrej Crishna 1.08%unchanged
Jamshyd Naoroji Godrej 1.08%unchanged
Nadir Godrej, Hormazd Godrej And Rati Godrej (Trustees Of Sng Family Trust) 0.45%unchanged
Nadir Godrej, Hormazd Godrej And Rati Godrej (Trustees Of Bng Family Trust) 0.45%unchanged
Nadir Godrej, Hormazd Godrej And Rati Godrej (Trustees Of Rng Family Trust) 0.45%unchanged
Nisaba Godrej & Pirojsha Godrej (Trustees Of Ng Family Trust) 0.45%unchanged
Pirojsha Adi Godrej 0.36%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Mutual funds in GODREJAGRO

Filings to Aug 2026

0 new, 0 added, 0 trimmed, 0 sold out — net +0.00 L shares (+0.0%).

Held by funds
₹247 Cr
1 schemes
Biggest holder
Nippon India Small Cap Fund
₹247 Cr · 0.3% of that fund
SchemeHoldingLast month
Nippon India Small Cap Fund Nippon India Mutual Fund₹247 Crheld

HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.

Mutual funds Aug 2026

0 added, 0 trimmed — net 0 shares (+0.0%)

Funds are sitting on
-9%
vs est. average cost
Held by funds
₹247 Cr
1 schemes · ≈ 2.1% of the company

Shares held by these funds +77%

Aug '23 40.21 L shares Jul '26

What the price assumes

Attractive

To justify its price of ₹676, this stock must grow earnings at 22% every year for 7 years. Our analysis caps realistic growth at ~25%. At that growth it is worth ₹804 — upside of 19%.

Growth the price implies
21.6% a year
for 7 years, fading to 4%
It has actually compounded at
24.5% a year
net profit, FY23–FY26 · EPS 25.1%
The gap
-0.0 pp
19% downside if it only repeats history
Price today ₹675.85 Value at the reference growth ₹803.94

Change the assumptions yourself →

All earnings calls (7)

Read the Q1 FY27 call →

Learn to analyse Godrej Agrovet Limited

Guides on how to read this kind of business and the numbers that matter.